Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials.
- Resource Type
- Article
- Source
- NPJ Vaccines; 3/29/2024, Vol. 9 Issue 1, p1-11, 11p
- Subject
EBOLA virus EBOLA virus disease VACCINIA VACCINES VIRUS diseases ANTIBODY formation - Language
- ISSN
- 20590105